TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Cash Flow

Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -510 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SVA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-10 4.2 -15 60 7.9 39 479 15,353 -771 106 -57 -510
8.1 6.5 5.3 4.9 5.1 4.8 4.0 87 157 145 114 104
0.3 1.0 2.4 1.0 4.3 3.0 10 7.7 149 0.0
0.9 1.0 0.1 9.0 25 18 82
-19 -2.3 -20 20 -44 -28 283 461 -1,081 278 -123 -377
11 5.3 13 12 5.6 11 128 720 403 146 98 49
-11 -4.5 -12 -12 -25 -42 -205 -3,024 -5,760 -2,926 4,386
0.6 0.0 0.0 0.0 0.0 0.0 1,876 263 328 947 3,513
0.6 0.8 0.3 1.7 85 21
1.2 -25 21 -5.6 -25 -1.2 574 -26 -4.3 239 123 100
5.3 -24 28 -1.3 64 1.7 593 -1,897 -241 -76 -824 -3,435
-17 -26 -1.4 51 42 -2.3 894 10,570 -7,333 -3,011 -527 554
-21 -1.1 -28 48 2.3 28 352 14,633 -1,174 -42 -154 -559

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?